Sooma Medical is specializing in neuromodulation therapies, and aims to provide effective and safe treatment options for psychiatric and neurological disorders, particularly Major Depressive Disorder (MDD) and chronic pain conditions like Fibromyalgia and Chronic Neuropathic Pain. Their therapies utilize transcranial direct current stimulation (tDCS), a noninvasive brain stimulation technique, delivered through their portable medical device, Sooma tDCS.

Therapies: Sooma offers two main therapies:

  1. Sooma Depression Therapy: Utilizes tDCS to modulate the function of the prefrontal areas of the brain, aiming to normalize hypoactivity of the left dorsolateral prefrontal cortex (DLPFC).
  2. Sooma Pain Therapy: Indicated for the treatment of Fibromyalgia and Chronic Neuropathic Pain, targeting the motor cortex to process pain signals.


  • Sooma Duo tDCS: The first EU MDR-certified tDCS system, combining the latest tDCS device with a digital platform for remote patient guidance and clinical management.
  • Sooma tDCS (GEN1): A complete therapy solution for MDD and chronic pain, featuring a high-quality stimulation device and accessories for home-based stimulation.

Key Features:

  • Effective and safe: Proven efficacy in placebo-controlled trials with drug-free treatments.
  • Portable: Sooma tDCS enables home-based treatment, increasing accessibility for patients.
  • Remote management: Sooma Duo facilitates remote patient guidance and clinical management, enhancing treatment optimization and compliance.

Research and Recognition:

  • Peer-reviewed studies: Sooma has published peer-reviewed studies demonstrating the efficacy of their therapies, including the largest dataset to date of tDCS use in real-world clinical practice.
  • FDA Breakthrough Device Designation: Sooma’s innovative at-home depression treatment device received FDA Breakthrough Device Designation, highlighting its potential clinical benefits.

Global Reach:

  • Presence in 35 countries: Sooma therapies are trusted and used by healthcare professionals worldwide, with over 20,000 patients benefiting from their treatments.

Future Directions:

  • Continuous innovation: Sooma aims to further develop their products and expand their treatment options to address a broader range of psychiatric and neurological disorders.

Sooma Medical stands at the forefront of neuromodulation therapies, offering effective and safe solutions for depression and chronic pain. With their innovative products, commitment to research, and global presence, Sooma continues to make significant strides in improving patient outcomes and accessibility to treatment.